It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The neuromodulation induced by neurofeedback training (NFT) remains a matter of debate. Investigating the modulation of brain activity specifically associated with NF requires controlling for multiple factors, such as reward, performance, congruency between task and targeted brain activity. This can be achieved using sham feedback (FB) control condition, equating all aspects of the experiment but the link between brain activity and FB. We aimed at investigating the modulation of individual alpha EEG activity induced by NFT in a double-blind, randomized, sham-controlled study. Forty-eight healthy participants were assigned to either NF (n = 25) or control (n = 23) group and performed alpha upregulation training (over 12 weeks) with a wearable EEG device. Participants of the NF group received FB based on their individual alpha activity. The control group received the auditory FB of participants of the NF group. An increase of alpha activity across training sessions was observed in the NF group only (p < 0.001). This neuromodulation was selective in that there was no evidence for similar effects in the theta (4–8 Hz) and low beta (13–18 Hz) bands. While alpha upregulation was found in the NF group only, psychological outcome variables showed overall increased feeling of control, decreased anxiety level and increased relaxation feeling, without any significant difference between the NF and the control groups. This is interpreted in terms of learning context and placebo effects. Our results pave the way to self-learnt, NF-based neuromodulation with light-weighted, wearable EEG systems.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Institut du Cerveau—Paris Brain Institute (ICM), INSERM U 1127, CNRS UMR 7225, Equipe Aramis, Sorbonne Université, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939); myBrain Technologies, Paris, France (GRID:grid.425274.2); INRIA, Aramis Project-Team, Paris, France (GRID:grid.5328.c) (ISNI:0000 0001 2186 3954)
2 myBrain Technologies, Paris, France (GRID:grid.5328.c)
3 Centre MEG-EEG, Institut du Cerveau—Paris Brain Institute—ICM, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939); CNRS, UMR 7225, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Inserm, U 1127, Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389); Sorbonne Université, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657)
4 myBrain Technologies, Paris, France (GRID:grid.462844.8)
5 CNRS, UMR 7225, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Inserm, U 1127, Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389); Sorbonne Université, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Equipe CIA—Cognitive Control, Interoception, Attention, Institut du Cerveau—Paris Brain Institute—ICM, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939); AP-HP, Hôpital Pitié-Salpêtrière, Service de Psychiatrie Adulte, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058)
6 myBrain Technologies, Paris, France (GRID:grid.411439.a)
7 CNRS, UMR 7225, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282)
8 Centre MEG-EEG, Institut du Cerveau—Paris Brain Institute—ICM, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939); CNRS, UMR 7225, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); Inserm, U 1127, Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389); Sorbonne Université, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Equipe Experimental Neurosurgery, Institut du Cerveau—Paris Brain Institute—ICM, Paris, France (GRID:grid.425274.2) (ISNI:0000 0004 0620 5939)